Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid × blinatumomab × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia 8 Burkitt Lymphoma 8 Recurrence 7 Lymphoproliferative Disorders 6 Lymphatic Diseases 5 Lymphoma, Non-Hodgkin 4 Immunoproliferative Disorders 4 Neoplasm, Residual 3 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Lymphoid 2 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Bites and Stings 1

Interventions

Imatinib Mesylate 5 ponatinib 4 Cytarabine 4 venetoclax 3 nilotinib 3 Mycophenolic Acid 3 thymoglobulin 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Cyclophosphamide 2 Antilymphocyte Serum 2 quizartinib 1 methanesulfonic acid 1 glasdegib 1 fludarabine 1 etoposide phosphate 1 enasidenib 1 daratumumab 1 bosutinib 1 asciminib 1 Whole-Body Irradiation 1 Transplantation 1 Temozolomide 1 Tacrolimus 1 Stem Cell Transplantation 1 Standard of Care 1 RFT5-SMPT-dgA immunotoxin 1 Peripheral Blood Stem Cell Transplantation 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡